Treatment Options for Anxiety Disorders
The recommended first-line treatments for anxiety disorders are Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and Cognitive Behavioral Therapy (CBT), which can be used alone or in combination depending on severity and patient preference. 1
Pharmacological Treatments
First-Line Medications
SSRIs
- Recommended as first-line pharmacotherapy with strong evidence 1, 2
- Options include:
- Escitalopram: Start 10 mg daily, can increase to 20 mg daily
- Sertraline: Start 25-50 mg daily, can increase to 200 mg daily
- Paroxetine and fluvoxamine are also effective 3
- Benefits: Good efficacy, favorable side effect profile, safe in overdose
- Duration: Continue for at least 6-12 months after symptom remission 1
SNRIs
- Alternative first-line option with efficacy comparable to SSRIs 1
- Options include:
- Venlafaxine: Start 37.5 mg daily, can increase to 225 mg daily
- May have more noradrenergic side effects (increased blood pressure, sweating) 1
- Caution: Venlafaxine may be associated with greater suicide risk and discontinuation symptoms 3
Second-Line Medications
Non-benzodiazepine anxiolytics
- Buspirone: Start 5 mg twice daily, maximum 20 mg three times daily 1
- Takes 2-4 weeks to become effective
Benzodiazepines
Psychological Interventions
Cognitive Behavioral Therapy (CBT)
- Highly effective for treating anxiety disorders 1
- Structure: Typically 14 sessions over 4 months, each session lasting 60-90 minutes 3
- Individual CBT is superior to group therapy in both clinical and economic effectiveness 3, 1
- Key components:
- Psychoeducation on anxiety
- Cognitive restructuring
- Gradual exposure to feared situations
- Relaxation techniques
- Problem-solving and social skills training
Self-help with CBT support
Combination Therapy
- Combining CBT with an SSRI may be more effective than either treatment alone, particularly for:
- Moderate to severe anxiety
- Patients who haven't responded adequately to monotherapy
- Individuals with comorbid depression 1
Treatment Algorithm
Initial Treatment:
- Start with either an SSRI (sertraline or escitalopram) or CBT based on:
- Patient preference
- Treatment availability
- Severity of symptoms
- Presence of comorbidities
- Start with either an SSRI (sertraline or escitalopram) or CBT based on:
Assess response after 4-6 weeks:
- If good response: Continue treatment for at least 6-12 months after symptom remission
- If partial response: Consider dose optimization or adding the other modality (add CBT to medication or vice versa)
- If poor response: Switch to another SSRI or SNRI, or consider alternative CBT approach
For treatment-resistant anxiety:
- Consider adding a second medication from a different class
- Select medications that may address both anxiety and comorbid conditions
- Consider referral to a specialist
Special Considerations
Medication discontinuation: Taper gradually to avoid withdrawal symptoms
Common pitfalls to avoid:
- Abrupt medication discontinuation causing withdrawal symptoms
- Overlooking comorbidities (depression, substance use)
- Long-term benzodiazepine use leading to dependence
- Premature discontinuation of treatment increasing relapse risk
Lifestyle modifications:
- Regular exercise, particularly in the morning
- Adequate sleep hygiene
- Mindfulness and meditation practices
- Limiting screen time before bed and upon waking 1
By following this structured approach to anxiety treatment, clinicians can effectively manage anxiety disorders while minimizing risks and maximizing quality of life outcomes for patients.